Clinical Case Study: Inovio’s Innovative Combination Trial

Time: 4:45 pm
day: Day Two

Details:

  • Optimizing T cell-generating therapies in combination with PD-1/PD-L1 inhibitors for GBM
  • Overview of the INO-5401 clinical trial and challenges to overcome in translation to phase 2 trials

Speakers: